ECTRIMS 2022 Amsterdam
Let's meet ...
Dr Wolf will attend the congress of the European Committee on Treatment and Research in Multiple Sclerosis from 26-28 October 2022 in Amsterdam in person.
Two presentations co-authored by Dr Wolf has been accepted for the conference:
P339 - Consensus recommendations on the use of follow-on disease-modifying treatments for multiple sclerosis.
W.J. Brownlee, C. Wolf, H.-P. Hartung, T. Dingermann, N. Anshasi, M. Trojano, K. Selmaj, B.M. Uitdehaag, C. Tur, J. Wuerfel, G. Dallmann, J. Witte, M.B. Sintzel, O. Bobrovnikova, J.A. Cohen (full text).
O120 - Assessment of dose-dependency of anti-inflammatory and neuroprotective efficacy variables and biomarkers for vidofludimus calcium in emphasis: a randomized, placebo-controlled phase 2 trial in relapsing-remitting multiple sclerosis.
Fox RJ, Wiendl H, Wolf C, De Stefano N, Sellner J, Gryb V, Rejdak K, Stoyanov Bozhinov P, Tomakh N, Skrypchenko I, Muehler AR (abstract).